Integrating network pharmacology and experimental validation to decipher the protective effect of icariin against

Jiandong Sun1, Chengyu Lv2, Zihang Lin3

  • 1Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fujian Medical University, Fuzhou 350122, PR China; Department of Histology and Embryology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, PR China; Department of Andrology, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350122, PR China; Department of Reproductive Medicine Centre, First Affiliated Hospital of Fujian Medical University, Fuzhou 350122, PR China.

PubMed

Insights

Icariin (ICA) combats male reproductive aging by reducing oxidative stress and activating the ESR1/AKT pathway. This natural compound restores testosterone synthesis and mitigates cellular senescence in aging testes.

Area of Science:

  • Reproductive Biology
  • Gerontology
  • Pharmacology

Background:

  • Male reproductive aging is characterized by increased reactive oxygen species (ROS) in testes, leading to reduced testosterone and impaired spermatogenesis.
  • Icariin (ICA), a bioactive monomer from traditional Chinese medicine, shows promise in protecting against ROS and environmental toxicants like DEHP.

Purpose of the Study:

  • To investigate the therapeutic effects of icariin on male reproductive senescence.
  • To elucidate the molecular mechanisms underlying icariin's protective effects in aged murine models.

Main Methods:

  • Integrated network pharmacology, molecular docking, and molecular dynamics simulations were employed to identify icariin's targets.
  • In vivo experiments utilized aged mice treated with icariin via oral gavage.

Main Results:

  • 125 potential targets of icariin in testicular aging were identified, linked to ROS scavenging, lipid metabolism, androgen synthesis, ferroptosis, and PI3K/AKT signaling.
  • Molecular docking and simulations confirmed high binding potential between icariin and key targets (ESR1, TP53, BCL2, HIF1A, TNF).
  • In vivo, icariin reduced ROS, malondialdehyde, and Fe2+ levels, activated the ESR1/AKT pathway, restored testosterone synthesis, and mitigated senescence in aging testes.

Conclusions:

  • Icariin demonstrates significant therapeutic potential in ameliorating male testicular aging.
  • The study provides a mechanistic basis for icariin's role in combating reproductive senescence via the ESR1/AKT pathway.